Literature DB >> 30094089

MicroRNA regulation of liver cancer stem cells.

Weiyang Lou1,2,3, Jingxing Liu4, Yanjia Gao5, Guansheng Zhong6, Bisha Ding1,2,3, Liang Xu1,2,3, Weimin Fan1,2,3,7.   

Abstract

MicroRNAs (miRNAs), a class of emerging small non-coding RNAs, serve as vital players in modulating multiple biological processes via the post-transcriptional regulation of gene expression. Dysregulated expression of miRNAs in liver cancer is well documented, and the involvement of miRNAs in liver cancer initiation and progression has also been described. Cancer stem cells (CSCs) are a subset of cells known to be at the root of cancer recurrence and resistance to therapy. In this review, we highlight recent reports indicating that miRNAs participate in the regulation of liver cancer stem cells (LCSCs). The Wnt signaling pathway, TGF-beta signaling pathway, JAK/STAT signaling pathway and epithelial-mesenchymal transition (EMT) are all closely correlated with the miRNA modulation of LCSCs. In addition, several miRNAs have been demonstrated to be involved in the regulation of LCSCs in response to therapy sensitivity. Targeting LCSCs by regulating the expression of these miRNAs represents a potential therapeutic strategy for treating cancer drug resistance, metastasis and recurrence in the near future.

Entities:  

Keywords:  EMT; MicroRNA (miRNA); cancer stem cell (CSC); chemo-resistance; liver cancer

Year:  2018        PMID: 30094089      PMCID: PMC6079154     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  121 in total

1.  Disparities in liver cancer occurrence in the United States by race/ethnicity and state.

Authors:  Farhad Islami; Kimberly D Miller; Rebecca L Siegel; Stacey A Fedewa; Elizabeth M Ward; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-06-06       Impact factor: 508.702

Review 2.  Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets.

Authors:  Marcel Klingenberg; Akiko Matsuda; Sven Diederichs; Tushar Patel
Journal:  J Hepatol       Date:  2017-04-22       Impact factor: 25.083

3.  Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4.

Authors:  Liang Li; Jing Tang; Baohua Zhang; Wen Yang; Miyang LiuGao; Ruoyu Wang; Yexiong Tan; Jianling Fan; Yanxin Chang; Jing Fu; Feng Jiang; Caiyang Chen; Yingcheng Yang; Jin Gu; Dingming Wu; Linna Guo; Dan Cao; Hengyu Li; Guangwen Cao; Mengchao Wu; Michael Q Zhang; Lei Chen; Hongyang Wang
Journal:  Gut       Date:  2014-02-26       Impact factor: 23.059

4.  The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor.

Authors:  Xiao-Lan Xu; Bao-Cai Xing; Hai-Bo Han; Wei Zhao; Mei-Hao Hu; Zuo-Liang Xu; Ji-You Li; Yong Xie; Jun Gu; Yu Wang; Zhi-Qian Zhang
Journal:  Carcinogenesis       Date:  2009-11-06       Impact factor: 4.944

5.  miRNA regulation of Sdf1 chemokine signaling provides genetic robustness to germ cell migration.

Authors:  Alison A Staton; Holger Knaut; Antonio J Giraldez
Journal:  Nat Genet       Date:  2011-01-23       Impact factor: 38.330

6.  miRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1.

Authors:  Qinying Liu; Yangmei Xu; Shenghong Wei; Wei Gao; Li Chen; Tong Zhou; Zhen Wang; Mingang Ying; Qiuhong Zheng
Journal:  Biosci Rep       Date:  2015-05-22       Impact factor: 3.840

7.  MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt/β-catenin signaling pathway.

Authors:  Zhiyun Zheng; Jimin Liu; Zhe Yang; Limin Wu; Haiyang Xie; Chaozhe Jiang; Binyi Lin; Tianchi Chen; Chunyang Xing; Zhikun Liu; Penghong Song; Shengyong Yin; Shusen Zheng; Lin Zhou
Journal:  Oncotarget       Date:  2016-05-10

8.  Overexpression of microRNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line.

Authors:  Jinghang Jiang; Peipei Yang; Zhe Guo; Rirong Yang; Haojie Yang; Fuquan Yang; Lequn Li; Bangde Xiang
Journal:  World J Surg Oncol       Date:  2016-10-28       Impact factor: 2.754

9.  Global miRNA expression analysis identifies novel key regulators of plasma cell differentiation and malignant plasma cell.

Authors:  Alboukadel Kassambara; Michel Jourdan; Angélique Bruyer; Nicolas Robert; Véronique Pantesco; Olivier Elemento; Bernard Klein; Jérôme Moreaux
Journal:  Nucleic Acids Res       Date:  2017-06-02       Impact factor: 16.971

10.  DDX3 Represses Stemness by Epigenetically Modulating Tumor-suppressive miRNAs in Hepatocellular Carcinoma.

Authors:  Hao-Kang Li; Ru-Tsun Mai; Hsien-Da Huang; Chih-Hung Chou; Yi-An Chang; Yao-Wen Chang; Li-Ru You; Chun-Ming Chen; Yan-Hwa Wu Lee
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

View more
  36 in total

1.  Resveratrol inhibits the migration, invasion and epithelial-mesenchymal transition in liver cancer cells through up- miR-186-5p expression.

Authors:  Feifeng Song; Yiwen Zhang; Zongfu Pan; Qi Zhang; Xixuan Lu; Ping Huang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-10-25

2.  Low adipocyte hepatocellular carcinoma is associated with aggressive cancer biology and with worse survival.

Authors:  Swagoto Mukhopadhyay; Yoshihisa Tokumaru; Masanori Oshi; Itaru Endo; Kazuhiro Yoshida; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

Review 3.  Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review.

Authors:  Riccardo Di Fiore; Sherif Suleiman; Rosa Drago-Ferrante; Yashwanth Subbannayya; Francesca Pentimalli; Antonio Giordano; Jean Calleja-Agius
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

4.  miR-122 and miR-197 expressions in hepatic carcinoma patients before and after chemotherapy and their effect on patient prognosis.

Authors:  Gang Zhan; Hui Jiang; Rui Yang; Kai Yang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

5.  Expression profile, molecular functions, and prognostic significance of miRNAs in primary colorectal cancer stem cells.

Authors:  Chuan-Wen Fan; Ran Lu; Chao Fang; Xue-Li Zhang; Zhao-Ying Lv; Yuan Li; Hong Zhang; Zong-Guang Zhou; Xian-Ming Mo; Xiao-Feng Sun
Journal:  Aging (Albany NY)       Date:  2021-04-01       Impact factor: 5.682

6.  Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.

Authors:  Xianzheng Qin; Yuning Song
Journal:  Med Sci Monit       Date:  2020-05-21

7.  Co-regulatory Network of Oncosuppressor miRNAs and Transcription Factors for Pathology of Human Hepatic Cancer Stem Cells (HCSC).

Authors:  Rania Hassan Mohamed; Nourhan Abu-Shahba; Marwa Mahmoud; Ahmed M H Abdelfattah; Wael Zakaria; Mahmoud ElHefnawi
Journal:  Sci Rep       Date:  2019-04-03       Impact factor: 4.379

8.  A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer.

Authors:  Wenlong Wang; Weiyang Lou; Bisha Ding; Beng Yang; Hongda Lu; Qingzhi Kong; Weimin Fan
Journal:  Aging (Albany NY)       Date:  2019-05-06       Impact factor: 5.682

Review 9.  Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.

Authors:  Saeedeh Keyvani-Ghamsari; Khatereh Khorsandi; Azhar Rasul; Muhammad Khatir Zaman
Journal:  Clin Epigenetics       Date:  2021-05-29       Impact factor: 6.551

10.  Five miRNAs-mediated PIEZO2 downregulation, accompanied with activation of Hedgehog signaling pathway, predicts poor prognosis of breast cancer.

Authors:  Weiyang Lou; Jingxing Liu; Bisha Ding; Luqi Jin; Liang Xu; Xia Li; Jing Chen; Weimin Fan
Journal:  Aging (Albany NY)       Date:  2019-05-06       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.